Asymmetry Capital Management as of Sept. 30, 2021
Portfolio Holdings for Asymmetry Capital Management
Asymmetry Capital Management holds 29 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alkermes (ALKS) | 6.9 | $12M | 373k | 30.84 | |
| Medtronic (MDT) | 6.3 | $11M | 84k | 125.34 | |
| Insulet Corporation (PODD) | 6.3 | $10M | 37k | 284.22 | |
| Hologic (HOLX) | 6.2 | $10M | 139k | 73.81 | |
| Sage Therapeutics (SAGE) | 6.1 | $10M | 229k | 44.31 | |
| Dice Therapeutics | 5.4 | $9.0M | 275k | 32.75 | |
| Arena Pharmaceuticals | 5.4 | $8.9M | 150k | 59.55 | |
| Cytokinetics (CYTK) | 5.3 | $8.8M | 246k | 35.74 | |
| Quanterix Ord (QTRX) | 4.8 | $8.1M | 162k | 49.79 | |
| Ptc Therapeutics I (PTCT) | 4.8 | $8.0M | 216k | 37.21 | |
| Mirati Therapeutics | 4.5 | $7.4M | 42k | 176.92 | |
| Astrazeneca Plc-spons Adr (AZN) | 4.2 | $7.0M | 116k | 60.06 | |
| Bellus Health | 4.0 | $6.6M | 1.1M | 6.14 | |
| Amicus Therapeutics (FOLD) | 3.8 | $6.2M | 654k | 9.55 | |
| Iveric Bio | 3.5 | $5.8M | 355k | 16.24 | |
| Kymera Therapeutics (KYMR) | 3.1 | $5.2M | 89k | 58.74 | |
| Baxter International (BAX) | 3.0 | $5.0M | 62k | 80.43 | |
| Avadel Pharmaceuticals Adr (AVDL) | 2.8 | $4.6M | 474k | 9.80 | |
| Aclaris Therapeutics (ACRS) | 2.6 | $4.4M | 242k | 18.00 | |
| Kura Oncology (KURA) | 2.2 | $3.6M | 194k | 18.73 | |
| Avidity Biosciences Ord (RNA) | 1.9 | $3.1M | 126k | 24.63 | |
| Pmv Pharmaceuticals (PMVP) | 1.8 | $3.0M | 101k | 29.80 | |
| Horizon Therapeutics | 1.6 | $2.7M | 25k | 109.54 | |
| Iteos Therapeutics (ITOS) | 0.9 | $1.5M | 57k | 27.00 | |
| Avalo Therapeutics | 0.7 | $1.2M | 535k | 2.18 | |
| Gemini Therapeutics | 0.7 | $1.1M | 284k | 4.04 | |
| Regulus Therapeutics | 0.6 | $968k | 1.4M | 0.69 | |
| Bcls Acquisition Corp | 0.4 | $730k | 73k | 9.96 | |
| Larimar Therapeutics (LRMR) | 0.2 | $403k | 35k | 11.53 |
